# Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement

> **NCT05283980** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 62 (actual)

## Conditions studied

- Pain, Postoperative
- Pain, Acute
- Pain, Chest
- Pain
- Satisfaction, Patient
- Opioid Use, Unspecified
- Opioids; Harmful Use

## Interventions

- **DRUG:** 0.25% Bupivacaine

## Key facts

- **NCT ID:** NCT05283980
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-17
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05283980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05283980, "Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05283980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*